IFNA1 and myeloproliferative neoplasm: Recently published data indicates that JAK2V617F‐mutant HSCs are hyper‐responsive to IFN, and that IFN signalling promotes megakaryocyte‐biased haematopoiesis, which may be an important determinant of MPN phenotype and disease evolution.19, 20